Why Analysts Are Quickly Raising Huntsman’s Target Prices
The analyst consensus target price for Huntsman is $37.55, which implies a return potential of 20.9%.
Dec. 14 2017, Updated 12:36 p.m. ET
![uploads///Part Recommendations](https://media.marketrealist.com/brand-img/3qxjy7yv3/480x251/uploads/2017/12/Part-4-Recommendations-1.png 480w, https://media.marketrealist.com/brand-img/3qxjy7yv3/640x335/uploads/2017/12/Part-4-Recommendations-1.png 640w, https://media.marketrealist.com/brand-img/3qxjy7yv3/768x402/uploads/2017/12/Part-4-Recommendations-1.png 768w, https://media.marketrealist.com/brand-img/3qxjy7yv3/1024x536/uploads/2017/12/Part-4-Recommendations-1.png 1024w, https://media.marketrealist.com/brand-img/3qxjy7yv3/1280x670/uploads/2017/12/Part-4-Recommendations-1.png 1280w, https://media.marketrealist.com/brand-img/3qxjy7yv3/1440x753/uploads/2017/12/Part-4-Recommendations-1.png 1440w, https://media.marketrealist.com/brand-img/3qxjy7yv3/1600x837/uploads/2017/12/Part-4-Recommendations-1.png 1600w, https://media.marketrealist.com/brand-img/3qxjy7yv3/2160x1130/uploads/2017/12/Part-4-Recommendations-1.png 2160w)
Analyst consensus on Huntsman
As of December 12, 2017, the number of analysts tracking Huntsman (HUN) has risen from eight analysts in July to 11 analysts at present. 91% of these analysts have recommended a “buy,” 9% have recommended a “hold,” while none of the analysts have recommended a “sell.”
The analyst consensus target price for Huntsman is $37.55, which implies a return potential of 20.9%. Analysts have been quickly raising HUN’s target price, which indicates their bullishness on the stock. The target prices have been moved from $30.10 in September to the current target price.
Most analysts lean towards a “buy”
Huntsman successfully spun off its pigments and performance additives business, which is now trading as Venator (VNTR). HUN posted strong 3Q17 earnings and reduced its debt from $4.5 billion to $2.4 billion on December 5. The company used the net proceeds from the secondary IPO to further reduce its debt by $471 million by redeeming the Term Loan B due in 2023. In total, HUN will reduce its interest expense by approximately $90 million per year. The debt repayments have helped HUN to improve its leverage ratio. Also, HUN still holds a 55% stake in VNTR. All these developments are expected to improve investor value. Thus more analysts are leaning towards a “buy” recommendation.
Individual brokerage recommendations
- Instinet has recommended a target price of $40, which implies a return potential of 28.7% based on its closing price of $31.07 on December 11, 2017.
- UBS (UBS) has given the stock a target price of $35, implying a return potential of 12.6% from the closing price as of December 11, 2017.
- Citigroup has raised its target price on Huntsman to $38.0, which implies a return potential of 22.3% from the closing price as of December 11, 2017.
Investors looking to invest in Huntsman indirectly can invest in the Vanguard Materials ETF (VAW), which has 0.70% exposure to Huntsman. The fund also provides exposure to Monsanto (MON) and LyondellBasell (LYB). These stocks have weights of 5.6% and 4.0%, respectively, as of December 11, 2017.